Net profit of Sigachi Industries rose 32.53% to Rs 21.35 crore in the quarter ended December 2024 as against Rs 16.11 crore during the previous quarter ended December 2023. Sales rose 25.66% to Rs 139.42 crore in the quarter ended December 2024 as against Rs 110.95 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales139.42110.95 26 OPM %23.7920.36 - PBDT31.3722.46 40 PBT26.7119.64 36 NP21.3516.11 33 Powered by Capital Market - Live News

Sigachi Industries will hold a meeting of the Board of Directors of the Company on 18 January 2025.Powered by Capital Market - Live News

Sigachi Industries has received reaffirmation in credit rating for bank facilities at CARE A-; Stable/ CARE A2. Powered by Capital Market - Live News

Sigachi Industries announced about its recent submission of CEP filing for �Propafenone Hydrochloride�. This is a significant step towards ensuring European regulatory standards and highest levels of product quality and safety. It will also strategically diversify Sigachi`s revenue channels to enhance greater value for all stakeholders involvedPropafenone Hydrochlride, widely used in the treatment of cardiac arrhythmias, is a highdemand API with a current global market size of USD 1.2 billion. Powered by Capital Market - Live News

Net profit of Sigachi Industries rose 43.76% to Rs 21.78 crore in the quarter ended September 2024 as against Rs 15.15 crore during the previous quarter ended September 2023. Sales rose 25.93% to Rs 124.90 crore in the quarter ended September 2024 as against Rs 99.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales124.9099.18 26 OPM %13.7921.59 - PBDT29.7720.74 44 PBT26.5518.21 46 NP21.7815.15 44 Powered by Capital Market - Live News